Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification
Authors
Keywords
-
Journal
JACC-Cardiovascular Interventions
Volume 15, Issue 3, Pages 321-332
Publisher
Elsevier BV
Online
2022-02-08
DOI
10.1016/j.jcin.2021.12.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management
- (2021) Felice Gragnano et al. JACC-Cardiovascular Interventions
- Device Therapy of Hypertension
- (2021) Felix Mahfoud et al. CIRCULATION RESEARCH
- Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
- (2021) Michel Azizi et al. LANCET
- Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
- (2021) Kazem Rahimi et al. LANCET
- Endovascular Baroreflex Amplification for Resistant Hypertension
- (2018) Monique E. A. M. van Kleef et al. CURRENT HYPERTENSION REPORTS
- Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
- (2018) David E Kandzari et al. LANCET
- Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
- (2018) Michel Azizi et al. LANCET
- Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in AdherenceNovelty and Significance
- (2017) Pankaj Gupta et al. HYPERTENSION
- Sustained Reduction of Blood Pressure With Baroreceptor Activation TherapyNovelty and Significance
- (2017) Peter W. de Leeuw et al. HYPERTENSION
- Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study
- (2017) Wilko Spiering et al. LANCET
- Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
- (2017) Raymond R Townsend et al. LANCET
- Global Disparities of Hypertension Prevalence and ControlClinical Perspective
- (2016) Katherine T. Mills et al. CIRCULATION
- Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension
- (2016) Karsten Heusser et al. HYPERTENSION
- Defined daily dose (DDD) and its potential use in clinical trials of resistant hypertension
- (2016) Rodrigo Modolo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A Controlled Trial of Renal Denervation for Resistant Hypertension
- (2014) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistant hypertension? Assessment of adherence by toxicological urine analysis
- (2013) Oliver Jung et al. JOURNAL OF HYPERTENSION
- Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients
- (2012) Stacie L. Daugherty et al. CIRCULATION
- Baroreflex Activation Therapy Lowers Blood Pressure in Patients With Resistant Hypertension
- (2011) John D. Bisognano et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Method of Mean Value Calculation as an Additional Source of Variability in Ambulatory Blood Pressure Measurement
- (2010) M. Frank et al. AMERICAN JOURNAL OF HYPERTENSION
- Prognostic Influence of Office and Ambulatory Blood Pressures in Resistant Hypertension
- (2008) Gil F. Salles et al. ARCHIVES OF INTERNAL MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started